Lisinopril and Hydrochlorothiazide
- Product NDC
- 71335-0230
- 11-digit product format
- 713350230
- Labeler code
- 71335
- Product ID
- 71335-0230_9d8e030d-5706-49ee-aae1-2750aa3c9af3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076262
- Marketing category
- ANDA
- Marketing start
- 2002-07-02
- Marketing end
- 2022-09-30
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0230-1 | 71335023001 | 30 TABLET in 1 BOTTLE (71335-0230-1) | 30 tablet | 2015-08-10 | 0000-00-00 | No | No | Current |
| 71335-0230-2 | 71335023002 | 90 TABLET in 1 BOTTLE (71335-0230-2) | 90 tablet | 2015-08-10 | 0000-00-00 | No | No | Current |
| 71335-0230-3 | 71335023003 | 100 TABLET in 1 BOTTLE (71335-0230-3) | 100 tablet | 2015-08-10 | 0000-00-00 | No | No | Current |
| 71335-0230-4 | 71335023004 | 60 TABLET in 1 BOTTLE (71335-0230-4) | 60 tablet | 2015-08-10 | 0000-00-00 | No | No | Current |
| 71335-0230-5 | 71335023005 | 360 TABLET in 1 BOTTLE (71335-0230-5) | 360 tablet | 2021-12-27 | 2022-09-30 | No | No | Current |
| 71335-0230-6 | 71335023006 | 4 TABLET in 1 BOTTLE (71335-0230-6) | 4 tablet | 2021-12-27 | 2022-09-30 | No | No | Current |